IP Library › Granted Patent US 10,946,134
Granted Patent B2
US 10,946,134 · App. 15/425,494 · Granted Mar 16, 2021

Systems and methods for treating blood

Inventor: Patrick Richard Spearman (The Woodlands, TX)
Assignee: Humanity Life Extension LLC
A61M1/369A61M1/14A61M1/16A61M1/1629A61M1/1698A61M1/36A61M1/3607A61M1/3615A61M1/3621A61M1/3627A61M1/3672A61M1/3687A61M2202/048A61M2205/3331A61M2205/3334A61M2205/3368A61M2205/366A61M2230/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,946,134
App. No.
15/425,494
Granted
Mar 16, 2021
Kind
B2
Abstract

According to some embodiments, a system may treat blood outside the body of a patient. The system may include at least one toxin removal system configured to process blood from at least two places on the patient's body at a rate, for example, of at least 0.5 liters per minute. The system may be configured to raise the pH level of the patient's blood by introducing a fluid at rate of at least 9 liters per hour.

Claims (21)

1. A system comprising:

at least one toxin removal system configured to process blood received from at least two different locations on a patient's body, wherein the at least one toxin removal system is configured to perform convection dialysis on at least a portion of the blood, the at least one toxin removal system configured to be capable of removing substances over 6000 Daltons from the blood; and

wherein the at least one toxin removal system is configured to process blood from the patient at a collective rate of between 0.9 and 3 liters per minute.

2. The system of claim 1 , wherein a first toxin removal system of the at least one toxin removal system is configured to perform convection dialysis at a collective rate of between 0.9 and 1.8 liters per minute.

3. The system of claim 1 , wherein the at least one toxin removal system is configured to introduce fluid at a collective rate of between 9 and 30 liters per hour into the patient's blood, the fluid configured to raise the pH level of the patient's blood.

4. The system of claim 1 , wherein the at least one toxin removal system is configured to introduce fluid at a collective rate of between 9 and 30 liters per hour into the patient's blood, the fluid configured to lower the pH level of the patient's blood.

5. The system of claim 1 , wherein the at least one toxin removal system is configured to be capable to remove contaminants between 6000 and 40,000 Daltons.

6. The system of claim 1 , wherein the at least one toxin removal system is coupled to at least one port, the at least one port coupled to a femoral vein of the patient.

7. The system of claim 1 , wherein the at least one toxin removal system is coupled to at least one port, the at least one port coupled to a jugular vein of the patient.

8. The system of claim 1 , wherein the at least one toxin removal system is coupled to at least one port, the at least one port coupled to a clavicle vein of the patient.

9. The system of claim 1 , wherein the at least one toxin removal system comprises a membrane having an effective surface area of between 1.8 and 18 square meters.

10. The system of claim 1 , wherein the at least one toxin removal system comprises a membrane having an effective surface area of between 2 and 5 square meters.

11. The system of claim 1 , wherein:

the at least one toxin removal system comprises a first toxin removal system configured to perform convection dialysis on blood received from a first location on the patient's body and a second toxin removal system configured to perform convection dialysis on blood received from a second location on the patient's body; and

the first and second toxin removal systems are configured to introduce substances into the blood at a collective rate of between 9 and 30 liters per hour.

12. The system of claim 11 , wherein:

the first location is at least one of the group consisting of: the left femoral vein, the left clavicle vein, and the left jugular vein; and

the second location is at least one of the group consisting of: the right femoral vein, the right clavicle vein, and the right jugular vein.

13. The system of claim 11 , wherein:

the first and second toxin removal systems are configured to process the blood at a collective rate of between 0.9 and 2 liters per minute; and

the first and second toxin removal systems are configured to introduce substances into the blood at a collective rate of between 15 and 30 liters per hour.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: SPEARMAN, PATRICK RICHARD
To: HUMANITY LIFE EXTENSION LLC
Reel/Frame 047666/0810 →
Continuity (6)
Continuation In Part 14623447 · Feb 16, 2015
Continuation In Part 14623455 · Feb 16, 2015
Provisional Application 61940628 · Feb 17, 2014
Provisional Application 61983752 · Apr 24, 2014
Provisional Application 62011451 · Jun 12, 2014
Related Publication 20170246375A1 · Aug 31, 2017
Cited By (2)
US 12,246,123 US 12,285,557